Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial

Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a transition and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T21:50:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-14T21:56:22.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T22:11:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Removal of the 403 error content and the Home link indicates the study details page now loads without the forbidden error. This change restores access to the trial information and the standard page layout for viewing the study details.
    Difference
    0.5%
    Check dated 2026-09-30T22:24:03.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page shows an access-denied 403 screen, replacing the study record with a generic header/footer and removing the usual study details and related sections.
    Difference
    17%
    Check dated 2026-09-23T21:46:54.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.6 to v3.7.0, reflecting a system-wide update to the ClinicalTrials.gov page; this change does not alter the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-09-16T21:56:52.000Z thumbnail image

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.